Role of Xanthophylls in Visual Function
NCT05794074 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2023-03-31
Summary
Ecy of lutein supplementation alone, or zeaxanthin supplementation alone, or a combination of both, compared to placebo, on the evolution of macular pigment density (MPOD) measured by fundus photography in XANTH-deficient patients receiving enteral nutrition.
Conditions
- Nutrition Deficiency (Xanth Deficiency) Due to A Particular Kind of Food
Interventions
- DIETARY_SUPPLEMENT
-
luteine and zeaxanthine
luteine and zeaxanthine
- DIETARY_SUPPLEMENT
-
luteine
luteine
- DIETARY_SUPPLEMENT
-
zeaxanthine
zeaxanthine
- DIETARY_SUPPLEMENT
-
Placebo
Placebo
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-01
- Primary Completion
- 2027-03-01
- Completion
- 2027-03-01
More Related Trials
-
Relationships Between Macular Pigment Optical Density and Lacquer Cracks in High Myopic Patients.
NCT02205632 ·Status: COMPLETED ·Phase: NA
-
MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin
NCT00568828 ·Status: UNKNOWN
-
Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration
NCT01528605 ·Status: COMPLETED ·Phase: NA
-
The Influence of Lutein Supplements on Age-related Macular Degeneration
NCT01042860 ·Status: COMPLETED ·Phase: NA
-
Lutein Influence on Macula of Persons Issued From Amd Parents
NCT01269697 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
NCT00060749 ·Status: COMPLETED ·Phase: PHASE1
-
Lutein for Age-Related Macular Degeneration
NCT00006202 ·Status: COMPLETED ·Phase: PHASE2
-
Carotenoid Supplementation and Retinal Health in Healthy Adults
NCT07314411 ·Status: RECRUITING ·Phase: NA
-
Investigation of the Genetic and Environmental Determinants of MP Including Response to Supplementation
NCT01778231 ·Status: COMPLETED ·Phase: NA
-
Effects of Xanthophylls on Optical Density
NCT01316198 ·Status: COMPLETED ·Phase: NA
-
Effect of Micronutrient Supplementation on the Intestinal Microbiota in Patients With Age-related Macular Degeneration - The Gut-Retina-axis Study
NCT06391411 ·Status: COMPLETED ·Phase: NA
-
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)
NCT00763659 ·Status: COMPLETED ·Phase: NA
-
Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients
NCT02136303 ·Status: UNKNOWN ·Phase: NA
-
Macular Pigment and Visual Performance in Glaucoma Patients
NCT03959592 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Carotenoid Supplementation and Normal Ocular Health
NCT02147171 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60
NCT00121589 ·Status: COMPLETED ·Phase: PHASE1
-
Association of MPOD Values With Blue Light.
NCT04779398 ·Status: COMPLETED
-
Study of the Macular Pigment by the Consumption of Corn With Strong Content in Zeaxanthine
NCT02113254 ·Status: TERMINATED ·Phase: NA
-
Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
NCT01527435 ·Status: COMPLETED
-
Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular Pigment
NCT01480700 ·Status: COMPLETED ·Phase: NA
-
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2)
NCT01648660 ·Status: COMPLETED ·Phase: NA
-
Effects of Lutein in Retinitis Pigmentosa
NCT00029289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Investigation of Macular Pigment Augmentation on Dark Adaptation
NCT00478439 ·Status: TERMINATED ·Phase: PHASE4
-
The Effect of Eggs and Egg Products on Macular Pigment
NCT00527553 ·Status: COMPLETED ·Phase: NA
-
Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration
NCT00443911 ·Status: UNKNOWN